{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T02:42:15Z","timestamp":1769654535463,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11904-025-00754-z","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:14:21Z","timestamp":1757920461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Liver Biopsy and Fine Needle Aspiration in Novel HBV Therapeutics in HIV and HBV Coinfection"],"prefix":"10.1007","volume":"22","author":[{"given":"Alexandra N.","family":"Willauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth E.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"754_CR1","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","volume":"360","author":"CL Thio","year":"2002","unstructured":"Thio CL, Seaberg EC, Skolasky R, Phair J, Visscher B, Mu\u00f1oz A, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the multicenter cohort study (MACS). Lancet. 2002;360:1921\u20136.","journal-title":"Lancet"},{"key":"754_CR2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.cld.2019.04.004","volume":"23","author":"DL Wyles","year":"2019","unstructured":"Wyles DL. Antiretroviral effects on HBV\/HIV co-infection and the natural history of liver disease. Clin Liver Dis. 2019;23:473\u201386.","journal-title":"Clin Liver Dis"},{"key":"754_CR3","first-page":"547","volume":"30","author":"KE Sherman","year":"2022","unstructured":"Sherman KE, Thomas DL. HIV and liver disease: a comprehensive update. Top Antivir Med. 2022;30:547\u201358.","journal-title":"Top Antivir Med"},{"key":"754_CR4","first-page":"14","volume":"31","author":"MA Corcorran","year":"2023","unstructured":"Corcorran MA, Kim N. Chronic hepatitis B and HIV coinfection. Top Antivir Med. 2023;31:14\u201322.","journal-title":"Top Antivir Med"},{"key":"754_CR5","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok ASF, McMahon BJ, Chang K, Hwang JP, Jonas MM, Brown RS, Bzowej NH, Wong JB. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1560\u201399.","journal-title":"Hepatology"},{"key":"754_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10238-022-00799-z","volume":"23","author":"AB Chowdhury","year":"2023","unstructured":"Chowdhury AB, Mehta KJ. Liver biopsy for assessment of chronic liver diseases: a synopsis. Clin Exp Med. 2023;23:273\u201385.","journal-title":"Clin Exp Med"},{"key":"754_CR7","first-page":"FC08","volume":"8","author":"R Mannan","year":"2014","unstructured":"Mannan R, Misra V, Misra SP, Singh PA, Dwivedi M. A comparative evaluation of scoring systems for assessing necro-inflammatory activity and fibrosis in liver biopsies of patients with chronic viral hepatitis. J Clin Diagn Res. 2014;8:FC08-12.","journal-title":"J Clin Diagn Res"},{"key":"754_CR8","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hep.22742","volume":"49","author":"DC Rockey","year":"2009","unstructured":"Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD, Diseases AA for the S of L. Liver biopsy. Hepatology. 2009;49:1017\u201344.","journal-title":"Hepatology"},{"key":"754_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2021.101773","volume":"46","author":"V Leroy","year":"2022","unstructured":"Leroy V, Chevaliez S, Decraecker M, et al. Non-invasive diagnosis and follow-up of chronic infection with hepatitis B virus. Clin Res Hepatol Gastroenterol. 2022;46:101773.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"2","key":"754_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12020239","volume":"12","author":"M Jachs","year":"2022","unstructured":"Jachs M, Hartl L, Bauer D, Simbrunner B, St\u00e4ttermayer AF, Strassl R, et al. Long-term outcome of HBV-infected patients with clinically significant portal hypertension achieving viral suppression. J Pers Med. 2022;12(2):239.","journal-title":"J Pers Med"},{"key":"754_CR11","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","volume":"381","author":"P Marcellin","year":"2013","unstructured":"Marcellin P, Gane E, Buti M, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet. 2013;381:468\u201375.","journal-title":"Lancet"},{"key":"754_CR12","doi-asserted-by":"publisher","first-page":"7869","DOI":"10.3748\/wjg.v21.i25.7869","volume":"21","author":"Y Xu","year":"2015","unstructured":"Xu Y, Zhang Y-G, Wang X, Qi W-Q, Qin S-Y, Liu Z-H, et al. Long-term antiviral efficacy of Entecavir and liver histology improvement in Chinese patients with hepatitis B virus-related cirrhosis. World J Gastroenterol. 2015;21:7869\u201376.","journal-title":"World J Gastroenterol"},{"key":"754_CR13","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/hep.31823","volume":"74","author":"RK Sterling","year":"2021","unstructured":"Sterling RK, King WC, Khalili M, et al. A prospective study evaluating changes in histology, clinical and virologic outcomes in HBV-HIV co\u2010infected adults in North America. Hepatology. 2021;74:1174\u201389.","journal-title":"Hepatology"},{"key":"754_CR14","doi-asserted-by":"publisher","first-page":"21426","DOI":"10.7448\/IAS.20.1.21426","volume":"20","author":"A Boyd","year":"2017","unstructured":"Boyd A, Bottero J, Miailhes P, Lascoux-Combe C, Rougier H, Girard P, Serfaty L, Lacombe K. Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV\u2013HBV patients treated with Tenofovir disoproxil fumarate in france: a prospective cohort study. J Int AIDS Soc. 2017;20:21426.","journal-title":"J Int AIDS Soc"},{"key":"754_CR15","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1093\/cid\/cix122","volume":"64","author":"MJ Vinikoor","year":"2017","unstructured":"Vinikoor MJ, Sinkala E, Chilengi R, et al. Impact of antiretroviral therapy on liver fibrosis among human immunodeficiency virus-infected adults with and without HBV coinfection in Zambia. Clin Infect Dis. 2017;64:1343\u20139.","journal-title":"Clin Infect Dis"},{"key":"754_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12981-021-00419-y","volume":"18","author":"R Yang","year":"2021","unstructured":"Yang R, Gui X, Ke H, Xiong Y, Gao S. Combination antiretroviral therapy is associated with reduction in liver fibrosis scores in patients with HIV and HBV co-infection. AIDS Res Ther. 2021;18:98.","journal-title":"AIDS Res Ther"},{"key":"754_CR17","doi-asserted-by":"publisher","first-page":"e2127","DOI":"10.1097\/MD.0000000000002127","volume":"94","author":"R Mohr","year":"2015","unstructured":"Mohr R, Schierwagen R, Schwarze-Zander C, Boesecke C, Wasmuth J-C, Trebicka J, Rockstroh JK. Liver fibrosis in HIV patients receiving a modern cART. Medicine. 2015;94:e2127.","journal-title":"Medicine"},{"key":"754_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/hep.30825","volume":"71","author":"RK Sterling","year":"2020","unstructured":"Sterling RK, King WC, Wahed AS, et al. Evaluating noninvasive markers to identify advanced fibrosis by liver biopsy in HBV\/HIV co-infected adults. Hepatology. 2020;71:411\u201321.","journal-title":"Hepatology"},{"key":"754_CR19","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jhep.2015.11.012","volume":"64","author":"WR Kim","year":"2016","unstructured":"Kim WR, Berg T, Asselah T, et al. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients. J Hepatol. 2016;64:773\u201380.","journal-title":"J Hepatol"},{"key":"754_CR20","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1097\/HEP.0000000000000431","volume":"78","author":"MG Ghany","year":"2023","unstructured":"Ghany MG, Buti M, Lampertico P, Lee HM, Faculty on behalf of the 2022 A-EH-HTEC. Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: report from the 2022 AASLD-EASL HBV-HDV treatment endpoints conference. Hepatology. 2023;78:1654\u201373.","journal-title":"Hepatology"},{"key":"754_CR21","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41575-022-00649-z","volume":"19","author":"A Kramvis","year":"2022","unstructured":"Kramvis A, Chang K-M, Dandri M, et al. A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook. Nat Rev Gastroenterol Hepatol. 2022;19:727\u201345.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"754_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100480","volume":"4","author":"T Boettler","year":"2022","unstructured":"Boettler T, Gill US, Allweiss L, Pollicino T, Tavis JE, Zoulim F. Assessing immunological and virological responses in the liver: implications for the cure of chronic hepatitis B virus infection. JHEP Rep. 2022;4:100480.","journal-title":"JHEP Rep"},{"key":"754_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100841","volume":"5","author":"B Testoni","year":"2023","unstructured":"Testoni B, Suarez AAR, Battisti A, et al. Evaluation of the HBV liver reservoir with fine needle aspirates. JHEP Rep. 2023;5:100841.","journal-title":"JHEP Rep"},{"key":"754_CR24","first-page":"767","volume":"67","author":"US Gill","year":"2018","unstructured":"Gill US, Pallett LJ, Kennedy PTF, Maini MK. Liver sampling: a vital window into HBV pathogenesis on the path to functional cure. Gut. 2018;67:767.","journal-title":"Gut"},{"key":"754_CR25","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1136\/gutjnl-2018-317071","volume":"68","author":"US Gill","year":"2019","unstructured":"Gill US, Pallett LJ, Thomas N, Burton AR, Patel AA, Yona S, Kennedy PTF, Maini MK. Fine needle aspirates comprehensively sample intrahepatic immunity. Gut. 2019;68:1493\u2013503.","journal-title":"Gut"},{"key":"754_CR26","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1136\/gutjnl-2022-328380","volume":"72","author":"L Allweiss","year":"2023","unstructured":"Allweiss L, Testoni B, Yu M, et al. Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure. Gut. 2023;72:972\u201383.","journal-title":"Gut"},{"key":"754_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41598-017-00111-0","volume":"7","author":"E-Q Chen","year":"2017","unstructured":"Chen E-Q, Feng S, Wang M-L, Liang L-B, Zhou L-Y, Du L-Y, Yan L-B, Tao C-M, Tang H. Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B. Sci Rep. 2017;7:173.","journal-title":"Sci Rep"},{"key":"754_CR28","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/jmv.24601","volume":"89","author":"N Chuaypen","year":"2017","unstructured":"Chuaypen N, Sriprapun M, Praianantathavorn K, Payungporn S, Wisedopas N, Poovorawan Y, et al. Kinetics of serum HBsAg and intrahepatic CccDNA during pegylated interferon therapy in patients with HBeAg-positive and HBeAg\u2010negative chronic hepatitis B. J Med Virol. 2017;89:130\u20138.","journal-title":"J Med Virol"},{"key":"754_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100817","volume":"5","author":"SC Kim","year":"2023","unstructured":"Kim SC, Wallin JJ, Ghosheh Y, et al. Efficacy of antiviral therapy and host\u2013virus interactions visualised using serial liver sampling with fine-needle aspirates. JHEP Rep. 2023;5:100817.","journal-title":"JHEP Rep"},{"key":"754_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/hep.31026","volume":"72","author":"I Carey","year":"2020","unstructured":"Carey I, Gersch J, Wang B, Moigboi C, Kuhns M, Cloherty G, et al. Pregenomic HBV RNA and hepatitis B core-related antigen predict outcomes in hepatitis B e antigen\u2013negative chronic hepatitis B patients suppressed on nucleos(t)ide analogue therapy. Hepatology. 2020;72:42\u201357.","journal-title":"Hepatology"},{"key":"754_CR31","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/hep.32634","volume":"77","author":"M Lisker-Melman","year":"2023","unstructured":"Lisker-Melman M, Wahed AS, Ghany MG, et al. HBV transcription and translation persist despite viral suppression in HBV\u2010HIV co\u2010infected patients on antiretroviral therapy. Hepatology. 2023;77:594\u2013605.","journal-title":"Hepatology"},{"key":"754_CR32","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/infdis\/160.4.577","volume":"160","author":"N Bodsworth","year":"1989","unstructured":"Bodsworth N, Donovan B, Nightingale BN. The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual men. J Infect Dis. 1989;160:577\u201382.","journal-title":"J Infect Dis"},{"key":"754_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.20411\/pai.v9i2.720","volume":"9","author":"K Sherman","year":"2024","unstructured":"Sherman K, Rouster S, Meeds H, et al. Diagnostic utility of pre-genomic hepatitis B RNA in the evaluation of HBV\/HIV coinfection. Pathog Immun. 2024;9:43\u201357.","journal-title":"Pathog Immun"},{"key":"754_CR34","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/infdis\/jiz607","volume":"221","author":"A Balagopal","year":"2020","unstructured":"Balagopal A, Hwang HS, Grudda T, Quinn J, Sterling RK, Sulkowski MS, et al. Single hepatocyte hepatitis B virus transcriptional landscape in HIV coinfection. J Infect Dis. 2020;221:1462\u20139.","journal-title":"J Infect Dis"},{"key":"754_CR35","doi-asserted-by":"publisher","first-page":"e140584","DOI":"10.1172\/jci.insight.140584","volume":"5","author":"A Balagopal","year":"2020","unstructured":"Balagopal A, Grudda T, Ribeiro RM, et al. Single hepatocytes show persistence and transcriptional inactivity of hepatitis B. JCI Insight. 2020;5:e140584.","journal-title":"JCI Insight"},{"key":"754_CR36","doi-asserted-by":"publisher","DOI":"10.1172\/jci184243","author":"M Taddese","year":"2025","unstructured":"Taddese M, Grudda T, Belluccini G, et al. Transcription of hepatitis B surface antigen shifts from CccDNA to integrated HBV DNA during treatment. J Clin Invest. 2025. https:\/\/doi.org\/10.1172\/jci184243.","journal-title":"J Clin Invest"},{"key":"754_CR37","doi-asserted-by":"publisher","first-page":"104391","DOI":"10.1016\/j.ebiom.2022.104391","volume":"87","author":"JM Zerbato","year":"2023","unstructured":"Zerbato JM, Avihingsanon A, Singh KP, et al. HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy. eBioMedicine. 2023;87:104391.","journal-title":"eBioMedicine"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-025-00754-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11904-025-00754-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-025-00754-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:03:52Z","timestamp":1769609032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11904-025-00754-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["754"],"URL":"https:\/\/doi.org\/10.1007\/s11904-025-00754-z","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"45"}}